Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus

被引:200
作者
Davis, DA
Rinderknecht, AS
Zoeteweij, JP
Aoki, Y
Read-Connole, EL
Tosato, G
Blauvelt, A
Yarchoan, R
机构
[1] NCI, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA
[3] NCI, Med Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V97.10.3244
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is substantial evidence that Kaposi sarcoma-associated herpesvirus (KSHV) plays an important role in the pathogenesis of all forms of Kaposi sarcoma (KS). It has been noted that KS commonly occurs in locations, such as the feet, where tissue may be poorly oxygenated. On the basis of this observation, the potential role of hypoxia in the reactivation of KSHV replication was explored by studying 2 KSHV-infected primary effusion lymphoma B-cell lines (BC-3 and BCBL-1) latently infected with KSHV. Acute and chronic exposure of these cells to hypoxia (11% O-2) induced KSHV lytic replication, as indicated by an increase in intracellular lytic protein expression and detection of virus in cell supernatants by Western immunoblotting. In addition, hypoxia increased the levels of secreted viral interleukin-6. Moreover, hypoxia enhanced the lytic replication initiated by the viral inducer 12-O-tetradecanoylphorbol-13-acetate. Desferoxamine and cobalt chloride, 2 compounds that increase the intracellular levels of hypoxia-inducible factor 1, were also able to induce KSHV lytic replication. These studies suggest that hypoxia is an inducer of KSHV replication. This process may play an important role in the pathogenesis of KS. (Blood. 2001;97:3244-3250) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:3244 / 3250
页数:7
相关论文
共 52 条
[1]   Kaposi's sarcoma [J].
Antman, K ;
Chang, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) :1027-1038
[2]   Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas [J].
Aoki, Y ;
Tosato, G .
BLOOD, 1999, 94 (12) :4247-4254
[3]   Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions [J].
Aoki, Y ;
Yarchoan, R ;
Braun, J ;
Iwamoto, A ;
Tosato, G .
BLOOD, 2000, 96 (04) :1599-1601
[4]   Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus [J].
Arvanitakis, L ;
Mesri, EA ;
Nador, RG ;
Said, JW ;
Asch, AS ;
Knowles, DM ;
Cesarman, E .
BLOOD, 1996, 88 (07) :2648-2654
[5]   G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [J].
Bais, C ;
Santomasso, B ;
Coso, O ;
Arvanitakis, L ;
Raaka, EG ;
Gutkind, JS ;
Asch, AS ;
Cesarman, E ;
Gerhengorn, MC ;
Mesri, EA .
NATURE, 1998, 391 (6662) :86-89
[6]   Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines [J].
Boshoff, C ;
Endo, Y ;
Collins, PD ;
Takeuchi, Y ;
Reeves, JD ;
Schweickart, VL ;
Siani, MA ;
Sasaki, T ;
Williams, TJ ;
Gray, PW ;
Moore, PS ;
Chang, Y ;
Weiss, RA .
SCIENCE, 1997, 278 (5336) :290-294
[7]   KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-RELATED BODY-CAVITY-BASED LYMPHOMAS [J].
CESARMAN, E ;
CHANG, Y ;
MOORE, PS ;
SAID, JW ;
KNOWLES, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18) :1186-1191
[8]   DIRECT MEASUREMENT OF WOUND AND TISSUE OXYGEN-TENSION IN POSTOPERATIVE-PATIENTS [J].
CHANG, N ;
GOODSON, WH ;
GOTTRUP, F ;
HUNT, TK .
ANNALS OF SURGERY, 1983, 197 (04) :470-478
[9]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[10]   Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma [J].
Chuck, S ;
Grant, RM ;
KatongoleMbidde, E ;
Conant, M ;
Ganem, D .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :248-251